|Articles|October 14, 2004

Prostate Ca scientist wins Nobel Prize in chemistry

The Royal Swedish Academy of Sciences has awarded Aaron Ciechanover, MD, DSc, the 2004 Nobel Prize in chemistry.

The Royal Swedish Academy of Sciences has awarded Aaron Ciechanover, MD, DSc, the 2004 Nobel Prize in chemistry.

Dr. Ciechanover, a scientist who receives funding from the Prostate Cancer Foundation, was recognized for his work on proteasome, a cellular machine that regulates the destruction of unneeded cell proteins. The proteasome is the target of the drug bortezomib (Velcade), which is being tested to treat prostate cancer and is approved to treat multiple myeloma.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Subscribe Now!

Related Content

Latest CME

Breakthroughs in Non–Muscle-Invasive Bladder Cancer: Advancing Patient Care Through Innovation in Treatment
Virtual Event

Breakthroughs in Non–Muscle-Invasive Bladder Cancer: Advancing Patient Care Through Innovation in Treatment

February 23, 2026

View more
Case-by-Case: Application of HIF-PHIs for the Treatment of Anemia in Patients With CKD
Video

Case-by-Case: Application of HIF-PHIs for the Treatment of Anemia in Patients With CKD

Glenn M. Chertow, MD, MPH; Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN; Preethi Yerram, MD

View more